skip to content

Office for Translational Research

 

Projects are reviewed and selected for funding by a panel of experts. Recent panels have been drawn from the following translational research experts:

- Dr John Skidmore (Chair), Chief Scientific Officer ALBORADA Drug Discovery Institute
Dr Tim Allsopp, Industry Expert in Residence at the University of Cambridge
Prof Margaret Ashcroft, Department of Medicine, University of Cambridge
Dr Sarah Bolton, Centre for Healthcare Equipment and Technology Adoption (CHEATA), Nottingham University Hospitals NHS Trust
Prof Steve Charnock-Jones, Department of Obstetrics and Gynaecology, University of Cambridge
Dr Lee Coney, Cell & Gene Therapy Catapult
Prof Timothy Eisen, Department of Oncology, University of Cambridge
Prof Andrew Grace, Department of Biochemistry, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust
Dr Stephanie Hopley, Apollo Therapeutics
Mr Stuart Kay, Director, Medtech Solutions Ltd
Prof David Jayne, Director of the Vasculitis and Lupus Service, Cambridge University Hospitals NHS Foundation Trust
Dr Rajesh Jena, Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
Prof Masashi Narita, Cancer Research UK Cambridge Institute
Dr John Pritchard, Industry Expert in Residence at the University of Cambridge
Prof Charlotte Summers, Department of Medicine, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
- Prof Michael Sutcliffe, Department of Engineering, University of Cambridge
Dr Dave Smith, Principal Scientist, AstraZeneca
Dr Neil Thompson, Independent Consultant
Dr Miles Parkes, Department of Medicine, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust
Dr Mark Toshner, Department of Medicine, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust and Royal Papworth Hospital NHS Foundation Trust
- Dr Sofia Villar, MRC Biostatistics Unit, University of Cambridge
Mr David Warwick, Director, eg technology
- Prof Anne Willis OBE, MRC Toxicology Unit, University of Cambridge